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Abstract The most common result of BRCA1/2 mutation
testing when performed in a family without a previously identified mutation is an uninformative negative test result.
Women in these families may have an increased risk for breast
cancer because of mutations in non-BRCA breast cancer predisposition genes, including moderate- or low-risk genes, or
shared environmental factors. Genetic counselors often encourage counselees to share information with family members, however it is unclear how much information counselees
share and the impact that shared information may have on
accuracy of risk perception in family members. We evaluated
85 sisters and daughters of women who received uninformative negative BRCA1/2 results. We measured accuracy of risk
perception using a latent variable model where accuracy was
represented as the correlation between perceived risk (indicators = verbal and quantitative measures) and calculated risk
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(indicators = Claus and BRCAPRO). Participants who reported more information was shared with them by their sister or
mother about her genetic counseling session had greater accuracy of risk perception (0.707, p=0.000) than those who reported little information was shared (0.326, p = 0.003).
However, counselees shared very little information; nearly
20 % of family members reported their sister or mother shared
nothing with them about her genetic counseling. Family members were generally not aware of the existence of a genetic
counseling summary letter. Our findings underscore the need
for effective strategies that facilitate counselees to share information about their genetic counseling sessions. Such communication may help their relatives better understand their cancer
risks and enhance risk appropriate cancer prevention.
Keywords Breast cancer . Genetic counseling .
Uninformative negative BRCA1/2 . Accuracy of risk
perception . Risk assessment . Summary letter . Family
communication . Claus . BRCAPRO . Gail . Numeracy .
Cancer related distress

Introduction
Breast cancer risk assessment has implications for both patients and their family members. A cancer risk assessment
includes evaluating the family pedigree and other risk factors,
as well as providing individualized interpretation of genetic
test results. Genetic counselors can help their patients understand what test results mean to them as well as their family
members in terms of risk for future cancer and appropriate
medical management. Counselors typically encourage their
patients to share information and test results with family members and to encourage family members, in turn, to share information with their primary care providers (Riley et al. 2012).

Information Shared by Counselee Influences Family Members’

The purpose of this study was to determine whether the accuracy of sisters’ and daughters’ perceptions of their own risk for
future breast cancer are improved when more information is
shared by their family members who received genetic counseling and received uninformative negative BRCA1/2 test results.
We hypothesized that women who receive more information
from their family members will have risk perceptions more
concordant with their calculated risks for breast cancer than
those receiving less information.

Background
Genetic counselors are responsible for identifying at-risk family members and helping their patients communicate information to family members. However, patients often do not share
information discussed during genetic counseling sessions with
their family members, and what they do share is often inaccurate (Vos et al. 2011b). The National Society of Genetic
Counselors (NSGC) recommends that an essential element
of disclosure is to Bidentify at-risk family members and provide [the] patient with tools to inform and educate family
members^ (Riley et al. 2012, p. 158). Because of concerns
about patient privacy the most common method counselors
use to disseminate risk information within the family is to suggest that patients share the information with relatives (Forrest
et al. 2010). Although patients are often willing to share information, research has shown that information is often not disseminated to all family members who may benefit from receiving it and the information that is shared is often inaccurate
(Forrest et al. 2003; Hayat Roshanai et al. 2010; MacDonald
et al. 2007; Vos et al. 2011b). Thus, many at-risk relatives lack
critical information that could help them better understand their
cancer risks and be aware of appropriate preventive and screening measures (Ersig et al. 2009; Vos et al. 2011b).
Much of the research on communication and risk perception among families at risk for breast cancer has focused on
families with a known BRCA1/2 mutation. Yet, the most common outcome of BRCA1/2 testing is an uninformative negative result, meaning a negative result in the absence of a
known family mutation. Members of these families may still
be at elevated cancer risk. It is recommended that in the absence of an identified mutation, risk be estimated based on a
pedigree evaluation including the types and ages of onset of
cancer in a family (National Comprehensive Cancer Network
2013c). Pedigrees may reveal a familial pattern of cancer with
an increased risk for breast cancer related to shared environment or low penetrance gene mutations (Berliner et al. 2013).
While these families may not carry the same level of risk as
BRCA1/2 positive families, risk may still be high enough to
recommend earlier onset of screening, screening breast MRI
and/ or chemoprevention (Freedman et al. 2011; National
Comprehensive Cancer Network 2013b). Thus, risk
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assessment, and individualized communication about genetic
test results by the counselor are important to family members
beyond the counselor’s immediate patient, even in the presence of an uninformative negative BRCA1/2 test result.
A primary goal of genetic counseling is to help people
accurately understand risk and make informed decisions based
on personal risk (Hilgart et al. 2012; Riley et al. 2012;
Smerecnik et al. 2009). It is believed that if people more accurately understand their risk, they are better prepared to take
appropriate actions to reduce and manage this risk (Haas et al.
2005). Research assessing accuracy of risk perception related
to breast cancer in families at elevated risk has primarily focused on women who received genetic counseling rather than
their family members (Hilgart et al. 2012; Tilburt et al. 2011;
Vos et al. 2011a). In the presence of an uninformative negative
test result within the family, family members do not often
come in for individual counseling. If they receive information
about their risk, family members must generally rely on
second-hand information shared by the counselee. Women
with uninformative negative test results are less likely to share
information obtained during genetic counseling sessions than
those who tested positive for mutations (Patenaude et al.
2006).
Risk perceptions can be measured using verbal or numeric
indicators. Health care providers tend to view successful risk
communication as the transmission of precise information,
expecting that patients should understand their risk as the
health care provider does (Collins and Street 2009, p. 1507).
Patients, on the other hand, may focus more on experiential
reasoning to understand risk communications, drawing upon
personal life experience and emotion (Collins and Street
2009). Indeed, many women have difficulty interpreting risk
information especially when it is presented in a numeric format (Leventhal et al. 1999; Schwartz et al. 1997). Often
women’s verbal and numerical risk estimates are not congruent (Smerecnik et al. 2009). Women tend to underestimate risk
when using verbal comparative scales but overestimate their
numeric risk (Lipkus et al. 2000; Woloshin et al. 1999). Thus,
multiple measures of risk perception may more accurately
assess the concept than a single indicator.

Methods
Study Population
Participants included sisters and daughters of women who had
a personal history of breast cancer and received uninformative
negative BRCA1/2 test results from a board certified genetic
counselor. Participants were between the ages of 40–74.
Women were excluded if they ever received breast cancerrelated genetic testing, had received a prophylactic bilateral
mastectomy or oopherectomy, had a personal history of any
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type of cancer other than non-melanoma skin cancer, and/or if
they were of Ashkenazi Jewish descent as the associated highrisk status with this ancestry necessitates special consideration
in evaluating risk.
Participants were referred to the study by their sisters or
mothers with breast cancer who had received genetic counseling either as part of the Risk Education & Assessment for
Cancer Heredity (REACH) study, a population-based randomized equivalency/non-inferiority cluster randomized trial
of remote in-person vs. telephone BRCA1/2 counseling and
testing or through the clinical genetic counseling service at
Huntsman Cancer Institute (Kinney et al. 2014). The counselees who referred participants to our study had received both
pre- and post-test genetic counseling either by telephone or in
person (based on random assignment) by one of five genetic
counselors from a single clinic. Additionally, counselees received standardized summary letters indicating that close relatives may be at increased risk for breast cancer and may need
more intensive breast cancer surveillance, possibly including
breast MRI. Counselees were encouraged to share this information with their close relatives (our potential participants)
and encourage their relatives to share that information with
their primary care providers.
Procedures
All procedures were approved by and in accordance with the
ethical standards of the University of Utah Institutional
Review Board and with the Helsinki Declaration of 1975, as
revised in 2000. Informed consent was obtained from all patients for being included in the study. Potential participants
were mailed introductory letters followed by telephone calls
to assess for eligibility and invite them to participate. Eligible
women who agreed to participate were sent a packet in the
mail with a survey and a family history collection tool. They
also completed a telephone interview to review their family
pedigree and ask additional questions. Prior to the telephone
interview a pedigree was drawn from the self-reported family
history. Women were asked if they wanted to receive their 5year and lifetime risk estimates by the three models used.
Women who completed the study were thanked with a mailed
$25.00 prepaid gift card and, for those who desired, their
breast cancer risk estimates.
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strong framework for studying risk perception based on family history information (Marteau and Weinman 2006; Sivell
et al. 2008). We view risk perception as a cognitive response
to the health threat of breast cancer (having a close family
member with breast cancer who has received genetic counseling and testing). This cognitive response can be simultaneously influenced by other cognitive factors (numeracy, knowledge, health literacy) as well as emotional factors (cancer related distress). Our primary aim was to evaluate the accuracy
of perceived risk (as compared to calculated risk levels) while
controlling for cognitive and emotional factors known to influence risk perception (Tilburt et al. 2011). Additionally we
aimed to assess the moderating effect of the amount of information shared by the counselee on the accuracy of risk perception in the family member. Supplemental Figure 1 illustrates the original model with proposed covariates.
Measures
Risk Perception
The mailed survey included two questions about perceived
risk for breast cancer. The initial question asked women to
rate their risk perception verbally asking, BIn your opinion,
compared to other women your age, what are your chances
of getting breast cancer?^ Women could respond on a 5-point
scale ranging from Bmuch lower^ to Bmuch higher.^ The second question presented women with a graphic showing 12 of
100 women shaded dark and stated, BOn average 12 women
out of 100 will get breast cancer in their lifetime.^ Then the
question instructed, BPicture yourself in a room with 100
women exactly like you (same risk-factors). How many of
you will get breast cancer in your lifetime?^ This question
was accompanied by a picture of 100 women with none shaded and the statement, Byou can pick any number between 0
and 100.^ A frequency format with graphic has been shown to
have a lower risk estimation error when compared to the percentage scales when estimating lifetime risk for breast cancer
(Cameron et al. 2011; Schapira et al. 2004). Asking the qualitative question first and providing an anchor population has
been shown to increase accuracy of risk perception (Apicella
et al. 2009; Dillard et al. 2006; Taylor et al. 2002).
Calculated Risk

Conceptual Framework
Our study was based broadly on the Common Sense Model of
Self-regulation (CSM) by Leventhal et al. (2003). The CSM
proposes that people respond to health threats with both cognitive and emotional reactions. Cognitive and emotional responses simultaneously influence one another and are the primary drivers of actions that people take to control the threat
and control fear. It has been proposed that the CSM provides a

Five-year and lifetime risks were calculated using the Claus,
BRCAPRO and Gail models. The ACS guideline specifically
recommends using models such as BRCAPRO, Claus or
Tyrer-Cuzick models (American Cancer Society 2014;
Saslow 2007), while the NCCN guidelines list Claus,
BRCAPRO, BOADICEA, and Tyrer-Cuzick as potential
models to be used when calculating lifetime risk for breast
cancer for the purpose of recommending breast MRI

Information Shared by Counselee Influences Family Members’

screening (National Comprehensive Cancer Network 2013b).
We selected the BRCAPRO and Claus models because they
were the models used by our site’s genetic counselors during
data collection. Claus and BRCAPRO lifetime risk estimates
were used as indicators for the latent variable calculated risk.
We chose not to include the Gail calculations in the latent
variable model because it does not take extensive family history into account and is therefore not an appropriate model to
use for lifetime risk calculation when determining medical
management (American Cancer Society 2014). The Gail model considers risk factors beyond the family history and is the
most frequently used model in primary care.
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different factors and estimates may vary widely between
models. Therefore we use the term Baccuracy^ recognizing
that it is a common term in the literature, but the term
Bagreement^ may hold less bias. We selected a novel approach
to measuring accuracy of risk perception that does not require
the calculation of a difference score or an arbitrary break in
risk categories. We operationalized the concept of accuracy of
risk perception as the level of agreement, or in statistical
terms, the path coefficient, between the latent variables
Bcalculated lifetime risk^ for breast cancer and Bperceived
lifetime risk^ (see Fig. 1 and section on statistical analysis).
Information Shared

Accuracy of Risk Perception
Some refer to the agreement between perceived risk and calculated risk as accuracy. Inherent in this terminology is the
assumption that the calculations are correct and women are
Baccurate^ if their perceptions are close to calculated estimates. However, every model calculates risk based on
Fig. 1 Path diagrams of final
model* illustrating the level of
agreement between calculated
risk and risk perception (accuracy
of risk perception) based on the
amount of information shared by
sisters and mothers about genetic
counseling sessions (standardized
estimates)

Women were asked to rate how much information their sister
or mother with breast cancer shared about her genetic counseling session on a scale of 0–5 with 0 indicating that the family
member shared no information and 5 indicating a great deal of
information shared. Similarly, women were asked to rate how
well they understood the information shared on a 0–5 scale

Low Amount of Information Shared
n = 68

-0.225

0.491

0.258

Accuracy of Risk Perception
0.326 (p=0.003)

1.000

0.702

0.846

0.827

High Amount of Information Shared
n = 17
-0.246

0.599

0.195

Accuracy of Risk Perception
0.707 (p=0.000)

1.000

0.702

0.877

0.892

* Chi-Square Test of Model Fit 22.550, df = 28 (p = 0.755); Difference in chi-square compared with model
constraining equal regressions of Perceived Risk on Calculated Risk = 4.79, df=1, (p =0.0287)

262

with 0 indicating that she understood none of the information
and 5 indicating that she understood a great deal. We also
asked whether women were aware of the summary letter, or
the informational pamphlet that was provided to their sisters/
mothers following their relative’s post-test genetic counseling.
Numeracy, Knowledge and Health Literacy
We assessed three cognitive variables known to influence risk
perception including numeracy, knowledge and health literacy
(Tilburt et al. 2011). Numeracy was measured using the 8-item
Rausch-based numeracy scale that assesses the users’ ability
to understand, manipulate and use numerical information including probabilities. Possible scores range from 0 to 8 with
higher scores indicating higher levels of numeracy (Weller
et al. 2012). The 27-item Breast Cancer Genetic Counseling
Knowledge Questionnaire (BGKQ) was used to assess knowledge about breast cancer genetics. Scores could range from 0
to 27 with higher scores indicating higher levels of knowledge
(Erblich et al. 2005). We assessed health literacy using the Set
of Brief Questions developed by Chew et al. (2004). Each of
the three questions has five response options that were scored
from 0 to 4. Questions included, BHow often do you have
someone help you read hospital materials?^ (Bnever^ to^
always^), BHow confident are you filling out medical forms
by yourself (Bnot at all^ to Bextremely^) and BHow often do
you have problems learning about your medical condition
because of difficulty understanding written information?^
(Bnever^ to Balways^). Total scores could range between 0
and 12 with higher levels indicating higher levels of health
literacy.
Psychological Distress
Distress was measured to assess the emotional response to
being at risk for breast cancer. We used the 15 item Impact
of Event Scale (Horowitz et al. 1979) which asks about how
frequently certain statements were true for the participant during the past 7 days ranging from Bnot at all^ to Boften.^
Instructions to women were, Bthinking about your family history of cancer, how often would you say…^ followed by a list
of comments made by people after stressful life events that are
thought to be indicators of distress.
Statistical Analyses
Descriptive statistics (percent and frequencies) were calculated using IBM SPSS software version 21. Latent variable
modeling was completed using Mplus software version 7 to
test the hypothesis that the amount of information shared by
women’s sisters or mothers who received genetic counseling
would increase the accuracy of perceptions about their personal breast cancer risk.

Himes et al.

Accuracy of risk perception was defined as the level of
agreement (continuous variable) between risk perception and
calculated risk. Figure 1 illustrates the accuracy of risk perception as the path arrow between Bperceived lifetime risk for
breast cancer^ and Bcalculated lifetime risk for breast cancer.^
We treated Bperceived lifetime risk for breast cancer^ and
Bcalculated lifetime risk for breast cancer as latent variables.
Latent variables are constructs that effect outcome but are
measured by other indicators (Borsboom et al. 2003; Byrne
2012; Kline 2010). For example, we expect that women have
a certain perception of risk and this perception will influence
the words they use to describe their risk (e.g., a verbal indicator such as Bhigher^ or Blower^ than average) and the number
they select to describe their risk (e.g., a numeric indicator such
as B15 %^). These measures capture overlapping aspects of
risk perception and using both gives a more comprehensive
view of risk perception.
Similarly, the latent variable Bcalculated lifetime risk^ lacks
a consensus or Bgold standard^ for measurement. Treating
Bcalculated lifetime risk for breast cancer^ as a latent variable
with two observed indicators (Claus and BRCAPRO) allows
stronger relationships to be revealed than using either measure
alone. With latent variable modeling, relationships between the
two latent variables can be more robust than multiple comparisons involving four observed indicators measured with error.
Although we calculated Gail scores we did not include those
as indicators of calculated lifetime risk in our latent variable
model because medical management for familial cancer risk
is primarily based on selected features of a patient’s family
history (National Comprehensive Cancer Network 2013a, b).
Given that risk perception is a complex concept our goal
was to control for significant covariates that could complicate
interpretation of our results. Selection of initial covariates was
informed in part by (Tilburt et al. 2011). Only significant
covariates were included in the final model. Covariates that
were evaluated but ultimately not included in the final model
included age, education and health literacy (see initial model
in Supplemental Figure 1). Retained, significant covariates
included numeracy, knowledge about breast cancer genetics
and distress (see Fig. 1).
Moderating Effect of Information Shared on Accuracy of Risk
Perception
To evaluate the key hypothesis, we relied on a classical understanding of moderation: is the relationship between two
variables different at different levels of a third variable? In this
study, we define Baccuracy^ as a relationship, the regression
of perceived risk on calculated risk. A high regression relationship denotes high accuracy in this sense. The moderation
question is whether the regression of perceived risk on calculated risk is different at high and low levels of information
shared (the third variable).

Information Shared by Counselee Influences Family Members’

263

To evaluate the moderating effect of information shared on
the relationship between perceived and calculated lifetime risk
for breast cancer we compared two models: one with moderation (allowing different slopes and intercepts for the regression of perceived risk on calculated risk) and one with no
moderation (with slopes and intercepts equal across levels of
information shared). We hypothesized that the amount of information shared by sisters and mothers about genetic
counseling would moderate the relationship between a
woman’s perception of her risk and objectively calculated risk
(accuracy of risk perception).
The variable Bamount of information shared^ was stratified
into high and low groups based on the amount of information
women reported their family member had shared with them
about the genetic counseling session. The low shared information group (n=68) included women who responded between 0 and 3 and the high group (n=17) included women
who responded 4–5 on the Information Shared scale.
Stratifying on the basis of all six options (0–5) was not feasible
due to the small sample size.

Results
Demographics
Of the 135 women who were mailed introductory letters, 98
were ultimately eligible and 85 completed both the survey and
the telephone interview (see Fig. 2). Participant ages ranged
from 40 to 71 with a mean of 52.2 (SD=8.9). Nearly all women (98.8 %) reported their race and ethnicity as non-Hispanic
White with one woman reporting her race as Asian. Age, race/
ethnicity and educational level were similar between nonparticipants who shared demographic information (n=11) and
study participants (see Table 1).
Risk Perceptions
More women perceived their lifetime risk for breast cancer as
being Bhigher^ or Bmuch higher^ (53 %) than other women
their age as opposed to Bthe same^ (32.5 %), or Blower^ or
Bmuch lower^ (13.2 %) using verbal measures. On average

Fig. 2 Flow of Participants

135 women contact
information provided
by REACH-Pilot study

135 attempted to call
13 unreachable
122 reached, invited to participate
11 refused
eligibility
screening

111 screened for eligibility

100 women agreed to participate,
mailed survey, scheduled phone
interview

98 ultimately eligible

10 withdrew
5 contacted PI to
withdraw
5 lost to follow-up

3 completed
interview
but not
survey

N =85 Final Sample

11 ineligible
initially

2 became ineligible developed breast cancer
after agreeing to
participate but before
survey or interview
completed
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Table 1 Demographics of
participants and nonparticipants

Category

nonparticipantsa

participants
n

(%)

Age

M

(SD)

52.2

(8.9)

n

(%)

M

(SD)

55.4

9.8

Race/ ethnicity
Non-Hispanic White
Asian

84
1

(98.8)
(1.2)

11
0

(100.0)
(0.0)

High school/ GED
Some college/ vocational

13
32

(15.3)
(37.6)

0
6

(0.0)
(54.5)

4 year degree
Graduate degree

28
12

(32.9)
(14.1)

2
3

(1.8)
(2.7)

85

(100.0)

11

(100.0)

Education

Total
a

Nonparticipant data were provided by 11 of 23 women who did not participate because they, refused screening,
withdrew, were lost to follow-up, or became ineligible. Other nonparticipants refused to provide demographic
data. Percentages are based on nonparticipants who provided data

women estimated their quantitative lifetime risk to be 25.62 %
(SD=19.94) with a range of 1-95 %.
Calculated Risk
Calculated 5-year and lifetime risk estimates by risk prediction
model are presented in Table 2. Additionally, the percentage
of women with lifetime risks greater than 15 and 20 % are
delineated.
Summary Letter & Informational Pamphlet
Women were asked whether they were aware that their sister
or mother received a summary letter about their genetic
counseling session. Only 12 women (14.3 %) reported that
they were aware of such a letter. Of those who were aware
of a letter, seven women saw the letter and two were
Table 2

Calculated risk

Model

[Range %]

M

(SD)

Lifetime

Lifetime

≥15 % risk

≥20 % risk

n

(%)

n

(%)

Gail
5-year
Lifetime
Claus
5-year
Lifetime
BRCAPRO
5-year
Lifetime

[0.6–12.0]
[8.3–38.8]

3.14
20.07

(2.3)
(6.6)

72

(84.5)

29

(34.1)

[0.2–5.7]
[2.0–38.3]

2.15
11.84

(1.2)
(6.7)

14

(16.5)

9

(10.6)

[0.8–2.2]
[4.0–14.7]

1.24
9.53

(0.5)
(2.0)

0

(0.0)

0

(0.0)

given a copy to keep. Three women reported that they
shared information about the letter with their primary
care provider. Two women reported that they provided
their primary care provider a copy of the letter. The 12
women who indicated they were aware of the letter
were asked to rate how strongly they felt that some of
the information in the letter applied to them with B0^
meaning that none of the information applies to them
and B5^ indicating that some of the information applies
strongly to them. Of the 12, seven women rated the
applicability of their sister or mother’s summary letter
at B4^ or greater.
Four women reported that they were aware of an informational pamphlet that their sister or mother received as a part of
the genetic counseling session. Two women reported that they
saw the pamphlet and one reported that she read it.
Covariates of Perceived Risk
Distress, knowledge, health literacy, numeracy, age and education were all considered as variables that could influence
perceived risk. As shown in Table 3, overall, women had
low levels of cancer-related distress, high levels of health literacy and average levels of numeracy and knowledge about
breast cancer genetics. Health literacy, age and education were
not significantly associated with risk perception and therefore
were not included in the final latent variable model. The relationships between retained covariates and perceived risk are
illustrated in Fig. 1 as the standardized path coefficients.
Numeracy and distress were associated with higher risk perception, but knowledge was inversely associated with risk
perception. Standardized path coefficients less than 0.10 indicate weak relationships, values around 0.30 represent a moderate association and values of 0.50 or more represent a strong
relationship between constructs (Kline 2010).

Information Shared by Counselee Influences Family Members’
Table 3 Instrument
performance: range, mean (SD)
and estimates of internal consistency reliability
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Variable

[range]

mean

(SD)

Cronbach’s Alpha
0.890

Distress (Impact of Events Scale)

[1–46]

8.20

(11.1)

Health Literacy (Set of Brief Questions)

[6–12]

10.91

(1.3)

0.511

Knowledge about Breast Cancer Genetics (BGKQ)
Numeracy (Rausch Based Numeracy Scale)

[1–24]
[2–8]

10.26
4.48

(5.5)
(1.5)

0.854
0.530

Note: n=85 for all instruments except numeracy. One participant refused to answer all numeracy questions and
was excluded from analysis of that instrument. The Impact of Events Scale categories are high distress > 19,
medium 8.5–19 and low <8.5 (Horowitz et al. 1979)

Amount of Information Shared and Understanding
Generally, women rated the amount of information shared by
their sisters and mothers about their genetic counseling sessions was low (see Table 4). Overall 18.8 % of women reported that their sisters or mothers did not share any information;
these women were not asked how well they understood information shared. Women reported high levels of understanding
the small amounts of information shared. As one woman stated during the interview, Ball she told me was ‘I’m negative,
but you should still get your mammograms’ – so that’s not
hard to understand.^ The families from which we recruited
were not identified as having any BRCA1/2 mutations, therefore none of the sisters or mothers were likely to have a true
negative test result. All of their relatives’ test results were
uninformative negatives.
Moderating Effect of Information Shared on Accuracy
of Risk Perception
The amount of information shared by counselees about their
genetic counseling sessions had a significant moderating
Table 4

effect on the accuracy of risk perception in their sisters and
daughters who did not attend genetic counseling (see Fig. 1).
In our sample, relatives who rated the amount of information
shared by counselees as high had more than twice the accuracy (standardized path =0.707, p=0.000) as those who rated the
amount of information shared as low (standardized path=
0.326, p=0.003) while controlling for distress, numeracy
and knowledge about breast cancer genetics. (Perfect correlation between perceived and calculated risk (perfect accuracy)
would yield a path coefficient of 1.0.) Thus in families where
counselees were perceived to share high amounts of information, sisters and daughters had more accurate perceptions of
their own lifetime risk for breast cancer.
A chi square test was conducted to assess significance of
the difference of deviance between the models. A difference in
chi-square between the model with moderation and the model
where the groups were constrained to be equal was Chi square
(df =1) =4.79, p=0.0287. This indicates significant improvement in model fit when the high and low amount of information shared groups are not constrained to be equal. Fit indices
for the alternative model assessing moderation effect of
amount of information shared were: Chi-Square Test of

Sharing/ understanding of information from family member’s genetic counseling session

Question

Response

Please rate on a scale of 0–5 how much information your sister/ mother
shared with you about what she learned in her genetic counseling
session, with zero being she shared nothing about the session to five
being she shared a great deal.

Shared nothing

Please rate how well you understand the information she shared on a
scale of 0–5 with zero being that you don’t understand it at all to five
being that you understand a great deal.

Shared a great deal
Total
Don’t understand at all

Understand a great deal
Total Valid
Nothing was shared
Total

0
1
2
3
4
5
0
1
2
3
4
5
69

n

(%)

M

SD

16
20
17
15
11
6
85
0

(18.8)
(23.5)
(20.0)
(17.6)
(12.9)
(7.1)
(99.9)
(0.0)

2.04

1.53

3.57

1.49

4
5
15
20
25
(81.2)
16
85

(4.7)
(5.9)
(17.6)
(23.5)
(29.4)
(18.8)
(100.0)

266

Model Fit (df =28)= 22.550, p =.7552, RMSEA =0.0000,
90 % CI [0.000–0.086]. A non-significant chi-square indicates
that the model-implied covariance matrix is consistent with
the population covariance matrix and supports the model, in
other words, the model and the data are not significantly different (Kline 2010, pp. 193, 200). RMSEA is below 0.05
indicating good model fit. Thus the model that allowed for
moderation was the better fitting model, indicating that increased amount of information shared by counselees about
their genetic counseling sessions influences the accuracy of
risk perception in their sisters and daughters who did not attend genetic counseling (see Fig. 1).

Discussion
A familial cancer risk assessment by its very nature produces
information that is valuable to the entire family. Our study is
among the first to demonstrate that the accuracy of risk perceptions is better among counselees’ relatives when they share
more information about their genetic counseling session with
them. In fact, with high amounts of information sharing, accuracy of risk perception in family members more than doubled. The salience of this finding is underscored given that
genetic counselors often encourage their patients to share information with family members. Our study provides evidence
that sharing makes a difference. It is noteworthy that the majority of our study’s participants reported that limited information was shared with them. Nearly 20 % reported that nothing
at all was shared about their family member’s genetic counseling session and over 80 % were considered in the low amount
of information shared group. Thus, our findings suggest that
communication could be improved in families where an uninformative negative BRCA1/2 test has been found. These findings are consistent with other literature indicating that women
with uninformative negative BRCA1/2 results are less likely to
share their test results with family (Cheung et al. 2010;
Patenaude et al. 2013). Our study is unique in that it elicited
information about perceptions of the amount of information
shared and did not focus specifically on test results.
The low amount of shared information does not necessarily
mean that families do not communicate. Indeed, our participants were referred to the study by their sisters and mothers
indicating that they had some contact with or knowledge
about their family members. It is possible that the low amount
of information shared about genetic counseling could indicate
that the information provided during genetic counseling was
not something counselees deemed worth sharing with their
close biological relatives because the genetic test result might
have been perceived as Bnegative^. Some women reported
that their sisters or mothers told them the cancer was, Bnot
hereditary.^ The observed low level of information sharing
in our study may be because the information was perceived
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as too complex to share in depth, or much of the information
was shared but our participants had limited recall.
The sisters and mothers of our participants received genetic
counseling according to a standardized protocol. A summary
letter and an informational pamphlet were provided as part of
test disclosure. Previous clinic patients had expressed the desire for an informational pamphlet specifically to help them
explain cancer genetics to their family members. We initially
thought that family members who were aware of or read the
summary letter and the informational pamphlet might have
more accurate risk perceptions. However, few women were
aware of the letter (14.1 %) or pamphlet (3.5 %), and even
fewer reported reading them; therefore we did not include
these variables in our latent variable model. Although very
few women were aware of a summary letter per se, we cannot
rule out that the summary letter may have helped counselees
convey information to their family members. Genetic counseling summary letters are not necessarily intended to be shared
with family members; they are typically written for the woman herself, perhaps with a section that applies to the extended
family.
It has been suggested that misperception of risk can increase or decrease use of screening and preventive services
(Tilburt et al. 2011). Higher risk perceptions are generally
associated with higher levels of screening (Katapodi et al.
2004; Walker et al. 2013). However, the ultimate goal is not
to undiscerningly increase screening and risk perception, but
to give women accurate risk information and achieve screening congruent with risk-based guidelines. The American
Cancer Society and the National Comprehensive Cancer
Network recommend that women with lifetime risk for breast
cancer of greater than 20 % be screened annually with breast
magnetic resonance imaging (MRI) in addition to mammography when risk is calculated with models that depend largely
on family history (National Comprehensive Cancer Network
2013b; Saslow 2007). The American Cancer Society further
suggests that there is currently not enough evidence to recommend for or against screening breast MRI when a woman’s
estimated lifetime risk is moderately increased (between 15
and 20 %) (American Cancer Society 2014). Over 10 % of
our participants were considered to be ≥20 % lifetime risk
according to the Claus model, yet none of them had been
offered or received screening breast MRI (Himes, et al., in
preparation). Thus, whether they had high or low levels of
accuracy or high or low amounts of information shared, the
highest risk women in our study had not been offered riskappropriate breast cancer screening.
Practice Implications
It is important that genetic counselors consider disclosure
methods that balance confidentiality with obligation to identify and inform family members that may be at higher risk

Information Shared by Counselee Influences Family Members’

(Godard et al. 2006). The duty to warn would suggest that, at
least for close biological relatives in whom high levels of risk
are suspected, the genetic counselor should facilitate the sharing of information among family members (Offit et al. 2004;
Stol et al. 2010; Suthers et al. 2006). Our findings suggest that
encouraging patients to share information with family members and providing a summary letter is not enough. Women
with an elevated lifetime risk for breast cancer may benefit
from annual breast MRI (Berg et al. 2012) (Kriege et al. 2004).
Yet most women at high risk are not receiving annual MRI
(Cohen 2010). Approximately 10 % of sisters and daughters
in our study population were considered at high risk but had
never received an MRI nor had one recommended by their
primary care provider (Himes, et al., in preparation). Women
with uninformative negative BRCA1/2 tests may require more
active psycho-educational interventions about what information to share with family members and strategies for sharing it.
Genetic counselors might consider a letter addressed to family
members that can be copied and hand delivered or mailed by
the counselee or request consent from the counselee for a
direct mailing of this information to their at-risk relatives.
Online sharing portals can also be used for sharing information among family members. If family members are not aware
of their risk they may not be aware of all screening and prevention options available to them.
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Study Limitations
Our study population was virtually all non-Hispanic white,
well-educated and limited to a single genetic counseling center limiting the generalizability of our findings to more underserved populations. Whenever family history is used to assess
risk there is the potential for inaccurate or incomplete cancer
information. However, the women in our study had sufficient
time to collect the required family history data. Further, many
participants conferred with other family members to obtain
data as accurately as possible, enhancing validity of family
history information. Studies comparing self-reported family
history with verified cases have yielded a high sensitivity for
breast cancer when compared to validation by chart review
(83–97 %) (Kerber and Slattery 1997) (Parent et al. 1997).
Because our study participants had participated in a previous
study about breast cancer prevention and that we asked them
to collect family history information for pedigree analysis, it is
possible that they may have heightened awareness of breast
cancer yielding higher distress scores and inflated risk perceptions. However, this does not appear to be the case given that
overall risk perceptions and distress scores were relatively
low.

Conclusion
Research Recommendations
Evidence-based genetic counseling interventions are needed
to promote effective family communication, and readily provide consultation to family members and their primary care
providers. It has been suggested that because many women
have a difficult time understanding familial cancer risk information, interpreting it, and communicating this information to
relatives, counselors should routinely either guide their patients in the communication process or inform relatives directly about risk and test results with counselee consent (ChanSmutko et al. 2008; Godard et al. 2006; Seymour et al. 2010;
Stol et al. 2010; Suthers et al. 2006; Vos et al. 2011a). There is
some evidence that family members prefer receiving risk information from a healthcare provider rather than from their
family member (Tunin et al. 2009). Future research is needed
to determine the feasibility, acceptability and effectiveness of
these strategies in the presence of uninformative negative
BRCA1/2 results when pedigree analysis indicates family
members may be at elevated risk. Specifically, researchers
should seek to establish the link between accurate risk perception and adherence to risk-based surveillance among those at
increased familial risk. Additionally, if this study is replicated
in the future it may be helpful to include the Tyrer-Cuzick
model for estimating breast cancer risk as part of the latent
variable model.

The most common result of BRCA1/2 mutation testing when
performed in a family without a previously identified mutation
is the uninformative negative test result. Women in these families may have an increased risk for breast cancer based on
family history. We evaluated sisters and daughters of women
who received an uninformative negative BRCA1/2 results and
found that most of them reported receiving very little information about the counseling session from their sister or mother. When more information was shared about the genetic
counseling session, sisters and daughters had more accurate
perceptions of their own risks for breast cancer. However, our
study participants reported that very little information was
shared. At-risk female relatives of counselees are generally
not aware of the existence of a genetic counseling summary
letter. Genetic counselors need to explore new ways to help
their patients share information with family members to help
family members perceive their risk for breast cancer more
accurately which could potentially allow family members to
pursue risk appropriate screening and prevention measures.
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